Frederick G. Vogt
CIK: 0001719678
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IOVANCE BIOTHERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (35 total)
- Sep 8, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct6.6K shares at avg. $8.70$58K - Sep 8, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct15.6K shares- - Sep 1, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct17.7K shares at avg. $8.28$147K - Sep 1, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct41.7K shares- - Jun 5, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct15.6K shares- - Jun 5, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct6.6K shares at avg. $4.23$28K - Jun 1, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct17.7K shares at avg. $3.96$70K - Jun 1, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct41.7K shares- - Mar 9, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
235K shares- - Mar 5, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct62.5K shares- - Mar 5, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct26.8K shares at avg. $4.58$123K - Mar 2, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct52.1K shares- - Mar 2, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct22.8K shares at avg. $3.79$86K - Dec 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct10.4K shares- - Dec 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct4.4K shares at avg. $2.14$9K - Dec 1, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct41.7K shares- - Dec 1, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct17.7K shares at avg. $2.23$39K - Sep 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct22.1K shares at avg. $2.19$48K - Sep 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct52.1K shares- - Jun 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct22.1K shares at avg. $1.76$39K - Jun 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct52.1K shares- - May 14, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Purchase(P)Direct25K shares at avg. $1.69$42K - Mar 5, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
187.5K shares- - Mar 3, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct95.4K shares at avg. $4.04$385K - Mar 3, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct223.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 6,638 | $8.70 | $57,751 | Direct |
| Sep 8, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 15,626 | - | $0 | Direct |
| Sep 1, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 17,702 | $8.28 | $146,573 | Direct |
| Sep 1, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 41,669 | - | $0 | Direct |
| Jun 5, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 15,625 | - | $0 | Direct |
| Jun 5, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 6,638 | $4.23 | $28,079 | Direct |
| Jun 1, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 17,701 | $3.96 | $70,096 | Direct |
| Jun 1, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 41,668 | - | $0 | Direct |
| Mar 9, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award(A) Restricted Stock Units | 235,000 | - | - | Direct |
| Mar 5, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 62,493 | - | $0 | Direct |
| Mar 5, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 26,755 | $4.58 | $122,538 | Direct |
| Mar 2, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 52,087 | - | $0 | Direct |
| Mar 2, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 22,809 | $3.79 | $86,446 | Direct |
| Dec 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 10,417 | - | - | Direct |
| Dec 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 4,426 | $2.14 | $9,472 | Direct |
| Dec 1, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 41,669 | - | - | Direct |
| Dec 1, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 17,701 | $2.23 | $39,473 | Direct |
| Sep 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 22,127 | $2.19 | $48,458 | Direct |
| Sep 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 52,086 | - | - | Direct |
| Jun 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 22,127 | $1.76 | $38,944 | Direct |
| Jun 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 52,085 | - | - | Direct |
| May 14, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Purchase(P) | 25,000 | $1.69 | $42,250 | Direct |
| Mar 5, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award(A) Restricted Stock Units | 187,500 | - | - | Direct |
| Mar 3, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 95,413 | $4.04 | $385,469 | Direct |
| Mar 3, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 223,943 | - | - | Direct |
1-25 of 35 transactions
About Vogt Frederick G
Vogt Frederick G (SEC CIK 0001719678) files insider reports with the SEC as Interim CEO & General Counsel of IOVANCE BIOTHERAPEUTICS, INC. (IOVA).
Signal8 holds 17 ownership filings by Vogt Frederick G, all Form 4s, filed between Sep 5, 2024 and Sep 10, 2026. Those filings report 35 transactions, from Sep 3, 2024 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Vogt Frederick G's filings is in SAN CARLOS, CA.
Recent filings by Vogt Frederick G
- Sep 8, 2026: Tax withholding of IOVA shares (Form 4, code F).
- Sep 8, 2026: Option exercise of IOVA shares (Form 4, code M).
- Sep 1, 2026: Tax withholding of IOVA shares (Form 4, code F).
- Sep 1, 2026: Option exercise of IOVA shares (Form 4, code M).
- Jun 5, 2026: Option exercise of IOVA shares (Form 4, code M).
Other insiders filing for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
- Berkowitz Noah, Chief Medical Officer
- BILINSKY IGOR, Chief Operating Officer
- Puri Raj K., Chief Regulatory Officer
- Kirby Daniel Gordon, Chief Commercial Officer
- Roche Corleen M., Chief Financial Officer
- WEISER MICHAEL, Director